DUR Newsletters
- Benzodiazepine ProDUR Edits
- Incoming and Outgoing Members of the DUR Commission
- Medicaid Statistics for Prescription Claims (FFS/MCO) September through November 2022
- Chronic Use of Controlled Sedative/Hypnotic Agents
- Medicaid Statistics for Prescription Claims (FFS/MCO) December 2021 through February 2022
- Ivermectin Misuse
- Helpful IME Information for Pharmacies and Pharmacists
- Medicaid Statistics for Prescription claims (FFS/MCO) September through November 2021
- Recent RetroDUR Initiatives
- Medicaid Statistics for Prescription claims (FFS/MCO) March through May 2021
- Safe Use of Benzodiazepine Drug Class
- Medicaid Statistics for Prescription claims (FFS/MCO) September through November 2020
- Iowa Medicaid Pharmacy DUR Program – SUPPORT Act Compliance
- Medicaid Statistics for Prescription claims (FFS/MCO) September through November 2019
- Annual Call for New Commission Member
- Gabapentinoid Abuse
- Medicaid Statistics for Prescription Claims (FFS/MCO) June 2019 through August 2019
- H.R. 6 (115th): SUPPORT for Patients and Communities Act
- Medicaid Statistics for Prescription Claims (FFS/MCO) December 2018 through February 2019